WAGNER TODD R 4

4 · H-CYTE, INC. · Filed Apr 8, 2021

Form 4

Period: 2020-09-24

10% Owner

Transactions

Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+226,566,264$3,171,928→ 226,566,264 total(indirect: (SEE FOOTNOTE))
From: 2020-09-24→ COMMON STOCK (226,566,264 underlying)
Other
STOCK PURCHASE WARRANTS
2020-09-24+265,868,613→ 265,868,613 total(indirect: (SEE FOOTNOTE))
Exercise: $0.01From: 2020-09-24→ COMMON STOCK (265,868,613 underlying)
Other
SERIES A PREFERRED STOCK
2020-09-24$0.01/sh+110,219,286$1,543,070→ 336,785,550 total(indirect: (SEE FOOTNOTE))
From: 2020-09-24→ COMMON STOCK (110,219,286 underlying)

Footnotes (6)

[F1]Held directly by FWHC Bridge, LLC (Bridge), and indirectly by Todd R. Wagner, the sole manager of Bridge. Each of the reporting persons disclaims beneficial ownership of the securities except to the extent of its or his pecuniary interest therein.
[F2]Received upon conversion of variable conversion price notes at closing of Qualified Financing. Note conversion price became fixed at closing. "Price of derivative securities" represents aggregate price paid for debt divided by number of shares received upon conversion of debt. Series A stock is convertible into common stock on a 1:1 basis.
[F3]Redeemable at option of requisite number of holders in specified circumstances.
[F4]Received in connection with variable conversion price notes. No additional consideration was paid for warrants, Exercise price became fixed at closing of Qualified Financing.
[F5]Purchased as part of backstop commitment in Qualified Financing. Series A stock is convertible into common stock on a 1:1 basis.
[F6]Not applicable.

Documents

1 file